Vevye (methylene blue topical) is used for the treatment of leukoplakia of the oral cavity [1].
How does Vevye work?
Vevye works by absorbing light and then releasing it as energy, which is toxic to abnormal cells [1].
What is leukoplakia?
Leukoplakia is a condition that causes white patches to form on the inside of the mouth [2]. These patches can be precancerous, meaning they have the potential to develop into oral cancer [3].
How is Vevye administered?
Vevye is applied topically to lesions in the mouth [1].
What are the risks associated with Vevye?
The most common side effect reported in clinical trials was staining of the oral mucosa, which can be addressed by adjusting the dose or frequency of application [1]. Other potential side effects include tooth staining, tongue staining, and gastrointestinal issues [4].
When does Vevye's patent expire?
Information on Vevye's specific patent expiry dates can be found on DrugPatentWatch.com [5].
What are other treatments for leukoplakia?
Treatment for leukoplakia depends on its cause and whether it is precancerous. Options can include surgical removal, laser therapy, or cryotherapy. In some cases, watchful waiting may be recommended if the leukoplakia is small and not causing symptoms [6].
What is the difference between Vevye and other oral treatments?
Vevye utilizes a photodynamic approach by absorbing light to target abnormal cells, which differentiates it from traditional surgical or ablative therapies [1].
Who makes Vevye?
Vevye is manufactured by NovaBiotics [7].
What clinical data supports Vevye's use?
Clinical trials have demonstrated Vevye's efficacy in reducing the size and appearance of leukoplakia lesions [1].
Can Vevye prevent oral cancer?
While Vevye treats leukoplakia, a precancerous condition, its direct role in preventing the progression to oral cancer is a subject of ongoing clinical evaluation [1][6].
What are patient concerns regarding Vevye?
Patients may have concerns about the cosmetic side effect of staining in the mouth and the potential for recurrence of leukoplakia [1][2].
---
1. Vevye [Internet]. Available from: https://www.drugs.com/stenabolic.html
2. Leukoplakia - Symptoms and causes [Internet]. Mayo Clinic; [cited 2024 Mar 10]. Available from: https://www.mayoclinic.org/diseases-conditions/leukoplakia/symptoms-causes/syc-20350411
3. Oral Leukoplakia - StatPearls - NCBI Bookshelf [Internet]. National Center for Biotechnology Information; [cited 2024 Mar 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559269/
4. VEVYE (Methylene Blue) topical [Internet]. DailyMed. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00704126-d260-497d-8c0a-34b64500b634
5. DrugPatentWatch.com [Internet]. Available from: https://drugpatentwatch.com/
6. Leukoplakia Treatment - StatPearls - NCBI Bookshelf [Internet]. National Center for Biotechnology Information; [cited 2024 Mar 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562218/
7. NovaBiotics Announces First Patient Dosed in Phase 2a Clinical Trial of NB-001 for the Treatment of Oral Leukoplakia [Internet]. NovaBiotics. Available from: https://www.novabiotics.com/news-releases/novabiotics-announces-first-patient-dosed-in-phase-2a-clinical-trial-of-nb-001-for-the-treatment-of-oral-leukoplakia/